Tenax Therapeutics
TENX • NASDAQ
Tenax Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher T. Giordano, with a market cap of $257.3M.
Market Cap$257.3M
Employees5.0
CEOChristopher T. Giordano
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Tenax Therapeutics FAQ
Common questions about Tenax Therapeutics
Tenax Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026.
Tenax Therapeutics has approximately 5 employees.